title: Obesity and nonadherence correlate with elevated serum estradiol levels in postmenopausal women receiving adjuvant aromatase inhibitor therapy.
authors.affiliation: Florida Hospital Cancer Institute, Orlando, Florida.
authors.forename: David A
authors.initials: DA
authors.lastname: Decker
authors.forename: Robert B
authors.initials: RB
authors.lastname: Reynolds
authors.forename: David C
authors.initials: DC
authors.lastname: Molthrop
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Griffith
authors.forename: Tiffany
authors.initials: T
authors.lastname: Encarnacion
authors.forename: Eimon
authors.initials: E
authors.lastname: Lee
authors.forename: Xiang
authors.initials: X
authors.lastname: Zhu
mesh_terms: D000368:Aged; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D004958:Estradiol / Q000097:blood; D005260:Female; D005431:Florida; D006801:Humans; D008875:Middle Aged; D009765:Obesity / Q000150:complications*; D010349:Patient Compliance; D017698:Postmenopause
chemical_list: D047072:Aromatase Inhibitors; D004958:Estradiol